Sat, Apr 19, 2014, 3:23 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sequenom Inc. Message Board

btommasino 1293 posts  |  Last Activity: 13 hours ago Member since: Dec 9, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Shareholders Meeting On May 21

    by bbarra1 19 hours ago
    btommasino btommasino 13 hours ago Flag

    Greenhill has had 8 month's to line up a BP. you maybe right I would have thought a deal would have been signed and announced contingent on FDA approval. This is not a good sign.

  • btommasino btommasino 18 hours ago Flag

    funny, today is a holiday.

  • Reply to

    Don't think "The House" enjoys

    by ociferdibble Apr 17, 2014 12:00 PM
    btommasino btommasino Apr 17, 2014 12:10 PM Flag

    you can recall them if you sell them.

  • btommasino by btommasino Apr 17, 2014 12:09 PM Flag

    Type message

    NEW YORK (GenomeWeb News) โ€“ Ariosa Diagnostics' first quarter revenues more than doubled year over year, the company said in an amended Form S-1 on Wednesday.

    For the three months ended March 31, revenues shot up to $19.5 million from $9.6 million in the first quarter of 2013 as revenues from its partnership with Laboratory Corporation of America, as well as from international customers, increased, the San Jose, Calif.-based developer of non-invasive prenatal tests said.

    Ariosa and LabCorp partnered in 2012 to make Ariosa's Harmony Prenatal Test available in the US and Canada. In the recently completed quarter, LabCorp-related revenues accounted for 62 percent of total revenues, down from 94 percent in the year-ago first quarter. During 2013 Ariosa entered into agreements with an additional unnamed US healthcare provider and with international clinics to offer Harmony, contributing to the year-over-year bump-up in revenues, it said.

    Revenues from its international business grew to $6.9 million in Q1 2014 from $583,000 in the year-ago period as test volume grew.

    Ariosa posted a profit of $1.1 million for the quarter, or break-even on a per share basis, compared to a net loss of $2.5 million, or $1.47 per share, a year ago.

    Its R&D expenses rose 19 percent to $4.3 million from $3.6 million, while its SG&A costs were up 61 percent to $8.2 million from $5.1 million.

    Ariosa finished the first quarter with $16.8 million in cash and cash equivalents.

    The company filed a preliminary prospectus with the US Securities and Exchange Commission last month for an initial public offering. Ariosa has not yet priced the IPO.


    NEW YORK (GenomeWeb News) โ€“ Ariosa Diagnostics' first quarter revenues more than doubled year over year, the company said in an amended Form S-1 on Wednesday.

    For the three months ended March 31, revenues shot up to $19.5 million from $9.6 million in the first quarter of 2013 as revenues from its partnership with Laboratory Corporation of America, as well as from international customers, increased, the San Jose, Calif.-based developer of non-invasive prenatal tests said.

    Ariosa and LabCorp partnered in 2012 to make Ariosa's Harmony Prenatal Test available in the US and Canada. In the recently completed quarter, LabCorp-related revenues accounted for 62 percent of total revenues, down from 94 percent in the year-ago first quarter. During 2013 Ariosa entered into agreements with an additional unnamed US healthcare provider and with international clinics to offer Harmony, contributing to the year-over-year bump-up in revenues, it said.

    Revenues from its international business grew to $6.9 million in Q1 2014 from $583,000 in the year-ago period as test volume grew.

    Ariosa posted a profit of $1.1 million for the quarter, or break-even on a per share basis, compared to a net loss of $2.5 million, or $1.47 per share, a year ago.

    Its R&D expenses rose 19 percent to $4.3 million from $3.6 million, while its SG&A costs were up 61 percent to $8.2 million from $5.1 million.

    Ariosa finished the first quarter with $16.8 million in cash and cash equivalents.

    The company filed a preliminary prospectus with the US Securities and Exchange Commission last month for an initial public offering. Ariosa has not yet priced the IPO.




    NEW YORK (GenomeWeb News) โ€“ Ariosa Diagnostics' first quarter revenues more than doubled year over year, the company said in an amended Form S-1 on Wednesday.

    For the three months ended March 31, revenues shot up to $19.5 million from $9.6 million in the first quarter of 2013 as revenues from its partnership with Laboratory Corporation of America, as well as from international customers, increased, the San Jose, Calif.-based developer of non-invasive prenatal tests said.

    Ariosa and LabCorp partnered in 2012 to make Ariosa's Harmony Prenatal Test available in the US and Canada. In the recently completed quarter, LabCorp-related revenues accounted for 62 percent of total revenues, down from 94 percent in the year-ago first quarter. During 2013 Ariosa entered into agreements with an additional unnamed US healthcare provider and with international clinics to offer Harmony, contributing to the year-over-year bump-up in revenues, it said.

    Revenues from its international business grew to $6.9 million in Q1 2014 from $583,000 in the year-ago period as test volume grew.

    Ariosa posted a profit of $1.1 million for the quarter, or break-even on a per share basis, compared to a net loss of $2.5 million, or $1.47 per share, a year ago.

    Its R&D expenses rose 19 percent to $4.3 million from $3.6 million, while its SG&A costs were up 61 percent to $8.2 million from $5.1 million.

    Ariosa finished the first quarter with $16.8 million in cash and cash equivalents.

    The company filed a preliminary prospectus with the US Securities and Exchange Commission last month for an initial public offering. Ariosa has not yet priced the IPO.

  • Reply to

    Did I just see $2.60's?

    by tradergirl131 Apr 16, 2014 3:55 PM
    btommasino btommasino Apr 17, 2014 10:03 AM Flag

    no follow thru yet.

  • btommasino by btommasino Apr 17, 2014 8:49 AM Flag

    Markets are closed tomorrow.

  • Reply to

    Qi CC announced

    by btommasino Apr 17, 2014 7:04 AM
    btommasino btommasino Apr 17, 2014 8:15 AM Flag

    Maybe we'll get one or two more PR's prior to the CC.

  • btommasino btommasino Apr 17, 2014 7:57 AM Flag

    Off by a week I hope you right on the rest of your call.

  • btommasino by btommasino Apr 17, 2014 7:04 AM Flag

    SAN DIEGO, April 17, 2014 /PRNewswire/ -- Sequenom, Inc. (SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the first quarter of 2014 after closing of the NASDAQ Global Market on Thursday, May 1, 2014.

    A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EDT (2:00 pm PDT) and will be webcast live on the Sequenom Web site.

  • btommasino btommasino Apr 16, 2014 8:55 PM Flag

    I wish, how about the mega millions number's in the mean time{)

  • Reply to

    Did I just see $2.60's?

    by tradergirl131 Apr 16, 2014 3:55 PM
    btommasino btommasino Apr 16, 2014 5:14 PM Flag

    well tomorrow is Friday as the market is closed for the holiday.

  • Reply to

    Unreal.

    by btommasino Apr 16, 2014 2:06 PM
    btommasino btommasino Apr 16, 2014 5:12 PM Flag

    yep, that 33k block sell at the close knocked it down from $2.61.

  • Reply to

    Fan / Quake have until May 23,2014 to

    by individuaione Apr 15, 2014 3:20 PM
    btommasino btommasino Apr 16, 2014 3:27 PM Flag

    You're right I didn't know these were new patents. ILMN could be lining up their bid right now.

  • Reply to

    Unreal.

    by btommasino Apr 16, 2014 2:06 PM
    btommasino btommasino Apr 16, 2014 3:01 PM Flag

    2400 shares in the last 20 minutes.

  • btommasino btommasino Apr 16, 2014 2:39 PM Flag

    when does the run up begin?

  • Reply to

    Fan / Quake have until May 23,2014 to

    by individuaione Apr 15, 2014 3:20 PM
    btommasino btommasino Apr 16, 2014 2:23 PM Flag

    Europe yes, but if the patents are invalid in the U.S. there is nothing you can't infringe when the patent is invalid.

  • btommasino by btommasino Apr 16, 2014 2:06 PM Flag

    there is no interest 300 shares traded in the last 8 minutes.

  • Reply to

    Fan / Quake have until May 23,2014 to

    by individuaione Apr 15, 2014 3:20 PM
    btommasino btommasino Apr 16, 2014 1:58 PM Flag

    indi, it is all contingent on CAFC upholding the 540 patent, otherwise we get nothing.

  • btommasino by btommasino Apr 16, 2014 12:26 PM Flag

    Record revenue. We will find out soon enough get back over $3. maybe $4.

  • btommasino btommasino Apr 16, 2014 12:23 PM Flag

    I hope so but it is the lightest volume in 2 weeks.

SQNM
2.590.00(0.00%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST